دورية أكاديمية

BRENTUXIMAB VEDOTIN FOR TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN A REAL WORLD SETTING: CLINICAL OUTCOMES AND IMPACT ON QUALITY OF LIFE.

التفاصيل البيبلوغرافية
العنوان: BRENTUXIMAB VEDOTIN FOR TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN A REAL WORLD SETTING: CLINICAL OUTCOMES AND IMPACT ON QUALITY OF LIFE.
المؤلفون: Ionova, T., Andrievskikh, M., Amdiev, A., Baryakh, E., Chang, V., Endakova, A., Fadeeva, N., Husainova, G., Ivanov, V., Kaplanov, K., Kaverina, O., Kiseleva, M., Klitochenko, T., Kurakin, V., Larionova, O., Lazareva, D., Lepik, K., Lysenko, I., Melnichenko, V., Mikhailova, N.
المصدر: Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-2, 2p
قاعدة البيانات: Complementary Index
الوصف
تدمد:02780232
DOI:10.1002/hon.67_2881